Metraipolis › archive › dc_b22acbb47373

Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41616036
DOI
10.1371/journal.pmed.1004930
License (as archived)
solo-consultazione
Archived
2026-11-06T10:00:58.008Z
SHA-256 of the archived text
67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070
Stable URL of this page
https://metraipolis.com/documento/dc_b22acbb47373

How to cite

Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036 — Europe PMC (en), https://europepmc.org/article/MED/41616036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b22acbb47373 (Metraipolis archive dc_b22acbb47373, sha256 67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070)
BibTeX
@misc{dcb22acbb47373,
  title = {Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy — Europe PMC PMID:41616036},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41616036},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b22acbb47373; sha256 67d71e1a609c51eff14685ea1a6f9360f0344b66636a3cd4c38edefc41803070},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41616036. Agents can read the archived copy with the MCP tool read_document.